These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 30661282)

  • 1. Hepatitis D virus infection, cirrhosis and hepatocellular carcinoma in The Gambia.
    Mahale P; Aka P; Chen X; Pfeiffer RM; Liu P; Groover S; Mendy M; Njie R; Goedert JJ; Kirk GD; Glenn JS; O'Brien TR
    J Viral Hepat; 2019 Jun; 26(6):738-749. PubMed ID: 30661282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis.
    Stockdale AJ; Kreuels B; Henrion MYR; Giorgi E; Kyomuhangi I; de Martel C; Hutin Y; Geretti AM
    J Hepatol; 2020 Sep; 73(3):523-532. PubMed ID: 32335166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demographics and outcomes of hepatitis B and D: A 10-year retrospective analysis in a Swiss tertiary referral center.
    Vieira Barbosa J; Sahli R; Aubert V; Chaouch A; Moradpour D; Fraga M
    PLoS One; 2021; 16(4):e0250347. PubMed ID: 33905426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular carcinoma in hepatitis D: does it differ from hepatitis B monoinfection?
    Abbas Z; Qureshi M; Hamid S; Jafri W
    Saudi J Gastroenterol; 2012; 18(1):18-22. PubMed ID: 22249087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B/D-Related Hepatocellular Carcinoma. A Clinical Literature Review.
    Baskiran A; Atay A; Baskiran DY; Akbulut S
    J Gastrointest Cancer; 2021 Dec; 52(4):1192-1197. PubMed ID: 34611832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transplantation of hepatitis B surface antigen-positive livers into hepatitis B virus-positive recipients and the role of hepatitis delta coinfection.
    Franchello A; Ghisetti V; Marzano A; Romagnoli R; Salizzoni M
    Liver Transpl; 2005 Aug; 11(8):922-8. PubMed ID: 16035057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis D: A Review.
    Negro F; Lok AS
    JAMA; 2023 Dec; 330(24):2376-2387. PubMed ID: 37943548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High rates of cirrhosis and severe clinical events in patients with HBV/HDV co-infection: longitudinal analysis of a German cohort.
    Bockmann JH; Grube M; Hamed V; von Felden J; Landahl J; Wehmeyer M; Giersch K; Hall MT; Murray JM; Dandri M; Lüth S; Lohse AW; Lütgehetmann M; Schulze Zur Wiesch J
    BMC Gastroenterol; 2020 Jan; 20(1):24. PubMed ID: 32000689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A population-based study of hepatitis D virus as potential risk factor for hepatocellular carcinoma.
    Ji J; Sundquist K; Sundquist J
    J Natl Cancer Inst; 2012 May; 104(10):790-2. PubMed ID: 22423008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B, C, and D virus infections in patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma: a comparative study in Niger.
    Cenac A; Pedroso ML; Djibo A; Develoux M; Pichoud C; Lamothe F; Trepo C; Warter A
    Am J Trop Med Hyg; 1995 Apr; 52(4):293-6. PubMed ID: 7537942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.
    Tsatsralt-Od B; Takahashi M; Nishizawa T; Endo K; Inoue J; Okamoto H
    J Med Virol; 2005 Dec; 77(4):491-9. PubMed ID: 16254981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of worse liver-related outcome according to HDV infection among HBsAg positive persons living with HIV: Data from the ICONA cohort.
    d'Arminio Monforte A; Tavelli A; Salpini R; Piermatteo L; D'Anna S; Carrara S; Malagnino V; Mazzotta V; Brancaccio G; Marchetti GC; Rosselli Del Turco E; Rossotti R; Mussini C; Antinori A; Lo Caputo S; Ceccherini Silberstein F; Gaeta GB; Svicher V; Puoti M;
    Liver Int; 2024 Feb; 44(2):603-613. PubMed ID: 38100128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and clinical course of hepatitis delta infection in Greece: a 13-year prospective study.
    Manesis EK; Vourli G; Dalekos G; Vasiliadis T; Manolaki N; Hounta A; Koutsounas S; Vafiadis I; Nikolopoulou G; Giannoulis G; Germanidis G; Papatheodoridis G; Touloumi G
    J Hepatol; 2013 Nov; 59(5):949-56. PubMed ID: 23850875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and clinical significance of hepatitis D virus co-infection in patients with chronic hepatitis B in Korea.
    Kim HS; Kim SJ; Park HW; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
    J Med Virol; 2011 Jul; 83(7):1172-7. PubMed ID: 21541950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel quantitative microarray antibody capture assay identifies an extremely high hepatitis delta virus prevalence among hepatitis B virus-infected mongolians.
    Chen X; Oidovsambuu O; Liu P; Grosely R; Elazar M; Winn VD; Fram B; Boa Z; Dai H; Dashtseren B; Yagaanbuyant D; Genden Z; Dashdorj N; Bungert A; Dashdorj N; Glenn JS
    Hepatology; 2017 Dec; 66(6):1739-1749. PubMed ID: 27880976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of hepatocellular carcinoma in hepatitis B and D virus co-infected patients: A systematic review and meta-analysis of longitudinal studies.
    Kamal H; Fornes R; Simin J; Stål P; Duberg AS; Brusselaers N; Aleman S
    J Viral Hepat; 2021 Oct; 28(10):1431-1442. PubMed ID: 34291520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis D virus dual infection increased the risk of hepatocellular carcinoma compared with hepatitis B virus mono infection: A meta-analysis.
    Chang TE; Su CW; Huang YS; Huang YH; Hou MC; Wu JC
    J Chin Med Assoc; 2022 Jan; 85(1):30-41. PubMed ID: 35006125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis D Viremia Among Injection Drug Users in San Francisco.
    Mahale P; Aka PV; Chen X; Liu P; Fram BJ; Wang AS; Simenel S; Tseng FC; Chen S; Edlin BR; Glenn JS; O'Brien TR
    J Infect Dis; 2018 May; 217(12):1902-1906. PubMed ID: 29800369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of HBV-HDV co-infection on HBV-HCC co-recurrence in patients undergoing living donor liver transplantation.
    Baskiran A; Akbulut S; Sahin TT; Koc C; Karakas S; Ince V; Yurdaydin C; Yilmaz S
    Hepatol Int; 2020 Sep; 14(5):869-880. PubMed ID: 32895876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of hepatitis B and hepatitis D coinfection in asymptomatic blood donors in Iran.
    Attaran MS; Sharifi Z; Hosseini SM; Samei S; Ataee Z
    APMIS; 2014 Mar; 122(3):243-7. PubMed ID: 23879563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.